Clinical Trial

Testing Treatment for Prostate Cancer

Study Description

Phase II High Dose Brachytherapy and Low Dose Rate Brachytherapy as Monotherapy in Localized Prostate Cancer

The purpose of this study is to evaluate the dose of High Dose Rate (HDR) brachytherapy chosen for this study as well as a commonly used alternate form of brachytherapy called low dose rate (or seed) brachytherapy. Investigators would like to understand how these treatments control the prostate cancer and look at their short and long term treatment related side effects.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Recruiting patients only Recruiting patients only

Radiation - Low dose rate brachytherapy

I-125 to a total dose of 144 Gy

Radiation - High dose rate brachytherapy

19 Gy in 1 fraction plus intraprostatic boost to GTV

Additional Information

Official Study Title

A Randomized Phase II Trial Evaluating Hight Dose Rate Brachytherapy and Low Dose Rate Brachytherapy as Monotherapy in Localized Prostate Cancer

Clinical Trial ID

NCT02960087

ParticipAid ID

nelmga